<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0025">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Damle</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vourvahis</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Leaney</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Corrigan</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19</article-title>. 
  <source>Clin Pharmacol Ther</source>. 
  <year>2020</year>;
  <volume>108</volume>(
  <issue>2</issue>):
  <fpage>201</fpage>â€“
  <lpage>11</lpage>. 
  <comment>[published online ahead of print, 2020 Apr 17]</comment>. doi:
  <pub-id pub-id-type="doi">10.1002/cpt.1857</pub-id>.
  <pub-id pub-id-type="pmid">32302411</pub-id>
 </mixed-citation>
</ref>
